首页|《肺癌在线自适应放射治疗中国专家共识》解读

《肺癌在线自适应放射治疗中国专家共识》解读

扫码查看
肺癌是我国发病率和死亡率最高的恶性肿瘤.精准放疗显著提高了肿瘤控制率、降低了不良反应,在肺癌治疗中发挥着重要作用,在图像引导放疗基础上发展起来的在线自适应放疗(adap-tive radiotherapy,ART)逐步进入临床.为规范ART在肺癌治疗中的临床应用,推动技术发展与临床协作,我国专家基于现有文献和临床经验,制定了《肺癌在线自适应放射治疗中国专家共识》.全文对该共识进行解读,梳理其产生背景、核心内容、亮点以及未来研究方向.
Interpretation of the Chinese Expert Consensus on Online Adap-tive Radiotherapy for Lung Cancer
Lung cancer is a malignant tumor with the highest morbidity and mortality.Precision radio-therapy significantly improves tumor control and reduces treatment-related toxicities,which plays a criti-cal role in treatment of lung cancer.With the rapid development of advanced technology,online adaptive radiotherapy(ART)based on image-guided radiotherapy has been widely applied in China.In order to standardize clinical application and to improve the cooperation of technology and scientific research,the Chinese Expert Consensus on Online Adaptive Radiotherapy for Lung Cancer has been developed.This paper interprets the consensus,focusing on its background,core content,highlights,and future re-search directions.

lung neoplasmsradiotherapyadaptive radiotherapyexpert consensusinterpretation

陈明

展开 >

华南恶性肿瘤防治全国重点实验室,广东省鼻咽癌诊治研究重点实验室,广东省恶性肿瘤临床医学研究中心,中山大学肿瘤防治中心,广东 广州 510060

中山大学-国科离子放射治疗前沿技术联合实验室,广东 广州 510060

肺肿瘤 放射疗法 自适应放疗 专家共识 解读

2024

肿瘤学杂志
浙江省肿瘤医院 浙江省抗癌协会

肿瘤学杂志

CSTPCD
影响因子:0.83
ISSN:1671-170X
年,卷(期):2024.30(12)